1. Home
  2. BNTC vs GLAD Comparison

BNTC vs GLAD Comparison

Compare BNTC & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.71

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

HOLD

Current Price

$18.55

Market Cap

427.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
GLAD
Founded
1995
2001
Country
United States
United States
Employees
N/A
65
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
360.7M
427.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNTC
GLAD
Price
$13.71
$18.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$27.67
$22.33
AVG Volume (30 Days)
86.2K
155.0K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
9.78%
EPS Growth
80.94
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.16
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
$11.70
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$16.54
52 Week High
$16.76
$29.50

Technical Indicators

Market Signals
Indicator
BNTC
GLAD
Relative Strength Index (RSI) 71.65 42.25
Support Level $12.79 $18.06
Resistance Level $14.35 $18.94
Average True Range (ATR) 0.74 0.45
MACD 0.32 -0.10
Stochastic Oscillator 96.74 18.98

Price Performance

Historical Comparison
BNTC
GLAD

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

Share on Social Networks: